MYLAN P157 (Metformin Hydrochloride and Pioglitazone Hydrochloride 850 mg / 15 mg (base))
Pill with imprint MYLAN P157 is White, Elliptical / Oval and has been identified as Metformin Hydrochloride and Pioglitazone Hydrochloride 850 mg / 15 mg (base). It is supplied by Mylan Pharmaceuticals Inc..
Metformin/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metformin/pioglitazone 850 mg / 15 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN P157
Metformin Hydrochloride and Pioglitazone Hydrochloride
- Imprint:
- MYLAN P157
- Strength:
- 850 mg / 15 mg (base)
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-1575
More about metformin/pioglitazone
- Metformin/pioglitazone Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 6 Reviews
- Drug class: antidiabetic combinations
Consumer resources
- Metformin and pioglitazone
- Pioglitazone and Metformin Extended-Release Tablets
- Pioglitazone and Metformin Tablets
- Pioglitazone and metformin (Advanced Reading)
Other brands: ActoPlus Met, ActoPlus Met XR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
